The CCRCB Drug Discovery lab is focused on the development of highly potent, selective and drug-like lead compounds for the treatment of human diseases.
Working for PIs in the University we have developed a number of small molecule protease inhibitor tool compounds, that are currently being utilized to validate their target proteins as bone-fide drug targets.
Dr Williams is available to supervise the following projects;
Our dedicated hub for postgraduate students, providing state-of-the-art facilities for study, and high-quality training and development programmes within a diverse interdisciplinary community.The gateway to your postgraduate experience
Queen's University Belfast is committed to Equality, Diversity and Inclusion.
For more information please read our Equality and Diversity Policy.
Queen's University Belfast is registered with the Charity Commission for Northern Ireland NIC101788
VAT registration number: GB 254 7995 11